| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |